<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 27-year-old woman with a history of aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> complained of poor control of her right arm and hand, <z:hpo ids='HP_0002317'>unsteady gait</z:hpo>, and <z:hpo ids='HP_0002315'>headache</z:hpo> that increased while in a recumbent position </plain></SENT>
<SENT sid="1" pm="."><plain>She was diagnosed with cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Additional investigation revealed <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with <z:chebi fb="5" ids="28304">heparin</z:chebi> was initiated but stopped after the patient developed a brain haemorrhage </plain></SENT>
<SENT sid="4" pm="."><plain>The patient recovered with no signs of residual symptoms and began taking oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> as maintenance therapy </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> is a rare acquired clonal disorder due to a defective expression of the glycosylphosphatidyl-<z:chebi fb="1" ids="24848">inositol</z:chebi> anchor membrane protein </plain></SENT>
<SENT sid="6" pm="."><plain>It is characterised by <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo>, diminished haematopoiesis, increased susceptibility for <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> have an increased risk of developing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In patients with cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> should be considered as a possible underlying disorder </plain></SENT>
<SENT sid="9" pm="."><plain>These patients should be questioned for possible clinical symptoms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>, such as <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002027'>abdominal pain</z:hpo> or dark urine in the morning </plain></SENT>
<SENT sid="10" pm="."><plain>For patients with these symptoms and in those with a history of aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo>, additional testing for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> should be conducted </plain></SENT>
</text></document>